80 likes | 103 Views
Novel Drugs and Devices to Lower Intraocular Pressure Market Report- 2020 Analyses competitive environment such as key players, future trends, growths, challenges and acquisitions in the market.
E N D
NOVEL DRUGS AND DEVICES TO LOWER INTRAOCULAR PRESSURE MARKET ANALYSIS INDUSTRY INSIGHTS, TRENDS, OUTLOOK, AND OPPORTUNITY ANALYSIS, 2020–2027 © Coherent market Insights. All Rights Reserved © Coherent market Insights. All Rights Reserved
REPORT DESCRIPTION Novel Drugs and Devices to Lower Intraocular Pressure Market - Overview Novel Drugs and Devices to Lower Intraocular Pressure Market, by Treatment Type (Drug (Rhopressa, Roclatan, Xelpros, Vyzulta and Others) and Device (Implant, Therapeutic Ultrasound and Others), by Distribution Channel (Hospitals & Clinics, Retail Channel and Online Channels), and by Region (North America, Latin America, Europe, Asia Pacific, Middle East, and Africa) – Size, Share, Outlook, and Opportunity Analysis, 2019 – 2027 Intraocular pressure is the pressure present inside the eye. The aqueous humour of the ciliary body in the eye is responsible for the intraocular pressure. The production and removal rate of aqueous humour by the ciliary body determines the pressure in the eye. The presence of extra fluid (aqueous humour) builds up pressure in the eye which can lead to glaucoma. There are two types of glaucoma, open–angle glaucoma and closed–angle glaucoma. Generally, tonometers are used for determining the pressure present in the eye. Global Novel Drugs and Devices to Lower Intraocular Pressure Market Drivers Approvals of drugs and devices associated with the treatment of glaucoma from regulatory bodies is expected to boost the global novel drugs and devices to lower intraocular pressure market growth. For instance, in May 2019, Ivantis Inc., received an approval from the U.S. Food and Drug Administration (FDA) for Hydrus microstent. It is a device used in minimally invasive glaucoma surgery. Browse Research Reports: https://www.coherentmarketinsights.com/ongoing-insight/novel- drugs-and-devices-to-lower-intraocular-pressure-market-2670 © Coherent market Insights. All Rights Reserved
REPORT DESCRIPTION Furthermore, in September 2018, Sun Pharmaceuticals Industries Ltd. received an approval from U.S. FDA for Xelpros (latanoprost ophthalmic emulsion) for treatment of glaucoma. It reduces the elevated intraocular pressure in the eye and has been designed with the help of Swollen Micelle Micro emulsion technology. Frequent approvals of drugs and devices is expected to accelerate global novel drugs and devices to lower intraocular pressure market growth. Key players are focused on monitoring post marketing results of approved drugs and devices for the treatment of glaucoma (Intraocular pressure), which is expected to drive the global novel drugs and devices to lower intraocular pressure market growth. For instance, Rhopressa drug manufactured by Aerie Pharmaceuticals was originally approved in December 2017 by U.S. Food and Drug Administration (FDA). The company is now studying the Rhopressa drug (Netarsudil ophthalmic solution) for its pharmacovigilance studies. The drug is being studied for its long-term effects on patients with open angle glaucoma and ocular hypertension. The study is expected to be completed by September 2019. Global Novel Drugs and Devices to Lower Intraocular Pressure Market Regional Analysis North America is expected to be dominant in global novel drugs and devices to lower intraocular pressure market during the forecast period. Factors such as government initiatives expected to augment the North America novel drugs and devices to lower intraocular pressure market growth. Request a Sample copy of this reports: https://www.coherentmarketinsights.com/insight/request-sample/2670 © Coherent market Insights. All Rights Reserved
REPORT DESCRIPTION Global Novel Drugs and Devices to Lower Intraocular Pressure Market Restraints Side effects of glaucoma medications are expected to hinder growth of the global novel drugs and devices to lower intraocular pressure market. Side effects of medications used for the treatment of glaucoma, such as Rhopressa, include internal bleeding, corneal deposits, and stinging. Also, the cost of these medications is very high. For instance, 2.5 milliliter’s of Rhopressa (Netarsudil ophthalmic solution) costs around US$269. Hence, these factors are expected to restrain the global novel drugs and devices to lower intraocular pressure market growth. Global Novel Drugs and Devices to Lower Intraocular Pressure Market Key Players Some of the major players operating in the global novel drugs and devices to lower intraocular pressure market include, Mati Therapeutics Inc, BioLight Lifesciences Ltd., IOPtima Ltd., Eye Sonix, Bausch & Lomb Inc., Sun Pharmaceutical Industries Ltd., Allergan, Alcon Inc., Glaukos Corporation, and Pfizer Inc. Global Novel Drugs and Devices to Lower Intraocular Pressure Market Taxonomy The global novel drugs and devices to lower intraocular pressure market is segmented on the basis of treatment, distribution channel, and region. Buy-Now this Research Report @ https://www.coherentmarketinsights.com/insight/buy-now/2670 © Coherent market Insights. All Rights Reserved
ABOUT COHERENT MARKET INSIGHTS ABOUT US Coherent Market Insights is a global market intelligence and consulting organization focused on assisting its plethora of clients achieve transformational growth by helping them make critical business decisions. We are headquartered in India, with an office at the global financial capital in the U.S. Our client base includes players from across all business verticals in over 150 countries worldwide. We are uniquely positioned to help businesses around the globe deliver practical and lasting results through various recommendations about operational improvements, technologies, emerging market trends and new working methods. We offer both customized and syndicated market research reports that help our clients create visionary growth plans to provide traction to their business. We meticulously study emerging trends across various industries at both the global and regional levels to identify new opportunities for our clientele. SERVICES CUSTOMIZED RESEARCH INDUSTRY ANALYSIS SYNDICATED RESEARCH COUNTRY SPECIFIC STUDIES MARKET INTELLIGENCE SERVICES CONSULT STUDIES © Coherent market Insights. All Rights Reserved
ABOUT CMI SECTOR COVERAGE BIOTECHNOLOGY CLINICAL DIAGNOSTIC HEALTHCARE IT MEDICAL DEVICES MEDICAL IMAGING PHARMACEUTICAL OUR CLIENTS Global Leading Equipment and System Manufacturers Marketing Consultancies and the Advertising Industry Component Providers and System Integrators Private and Government organization Distributors, Retailors and Value Added Resellers Outsourcing Companies Healthcare IT Solutions Developers Universities and Business Schools. © Coherent market Insights. All Rights Reserved
KEY STATS RESEARCH SOLUTIONS 100+ GLOBAL REPORTS FEASIBILITY STUDIES Insights Published Per Year CUSTOMIZED SOLUTIONS 150+ COUNTRY ANALYSIS Consulting Projects Till Date CONSULT PROJECTS SURVEY RESEARCH 125+ EXCEL FORECAST DATABASE Clients Worldwide Per Year COMPETITIVE ASSESSMENT TECHNOLOGY SNIPPETS 110+ Analysts and Contract Consultants Coherent Market Insights excels at offering unmatched actionable market intelligence across various industry verticals, including chemicals, healthcare, and food & beverages, to name a few. We implement holistic market research methodology in order to result in the best possible market research reports across various industries worldwide. Based on our unmatched expertise across various industries—no matter how large or small, how complex or unique—we help our clients achieve better outcomes with uniquely designed and highly customized solutions. Our coverage includes insights that help our clients ensure sustained growth in developed markets and also key inputs to help them tap into emerging markets and exploit the plethora of opportunities posed therein. © Coherent market Insights. All Rights Reserved
THANK YOU To know more about us, visit our website: www.coherentmarketinsights.com For sales queries or new topics email us on: sales@coherentmarketinsights.com For other queries contact: Mr. Shah (Manager - Business Development) Coherent Market Insights sales@coherentmarketinsights.com +1-206-701-6702 © Coherent market Insights. All Rights Reserved